NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,066.00
+65.00 (6.49%)
May 13, 2025, 3:30 PM KST
-45.45%
Market Cap 21.08B
Revenue (ttm) 170.38M
Net Income (ttm) -40.88B
Shares Out 19.77M
EPS (ttm) -414.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 808,828
Average Volume 702,300
Open 1,003.00
Previous Close 1,001.00
Day's Range 1,003.00 - 1,079.00
52-Week Range 985.00 - 2,120.00
Beta 0.82
RSI 45.44
Earnings Date May 15, 2025

About NeoImmuneTech

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 82
Stock Exchange KOSDAQ
Ticker Symbol 950220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.